Welcome to the Q2 2018 issue of our Life Sciences International Review, produced by our life sciences lawyers in the US, Europe, and Asia and covering some of the most critical developments in the pharmaceutical and medical technology sectors in the last quarter.
In this issue, we cover updates relating to:
Read the latest issue of the Life Sciences International Review >>